Illumina to Pay Affy $90M to Settle Patent Suits, Cease Litigation | GenomeWeb
 
NEW YORK (GenomeWeb News) - Illumina said today that it will pay Affymetrix $90 million to settle all ongoing lawsuits between the two companies and that both firms have agreed to a covenant not to sue for use of current and future products.
 
The agreement ends litigation between the companies in the US, Germany, and the UK dating back to 2004.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.